PMID: 9436473Jan 1, 1997Paper

Lipid risk factors of atherosclerosis: who, when, how to treat?

Annales d'endocrinologie
L FoubertG Turpin

Abstract

Hyperlipidemia, particularly hypercholesterolemia, is a well established risk factor for cardiovascular disease, specially coronary heart disease. Lipid-lowering therapies are associated with a reduction in cardiovascular morbidity and mortality in secondary as well as primary prevention. A precise lipid pattern is necessary before any treatment. The target level depends on the clinical data and associated cardiovascular risk factors. Diet is the first step approach and should always be continued. Cholestyramine and statins are the treatments of choice in case of hypercholesterolemia (type IIa). In case of isolated or associated hypertriglyceridemia (types IV and IIb) fibrates are the most efficient. No treatment is really efficient on Lp(a) level. A good observance is required for a lifelong treatment.

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Annales de cardiologie et d'angéiologie
R ChadarevianG Turpin
The American Heart Hospital Journal
Kevin A CourvilleRichard V Milani
Wiadomości lekarskie : organ Polskiego Towarzystwa Lekarskiego
J Gmiński
Cardiovascular Drugs and Therapy
J M McKenney
© 2021 Meta ULC. All rights reserved